Figure 1
From: The effects of high dose interferon-β1a on plasma microparticles: Correlation with MRI parameters
CD31. Levels of CD31+ (PECAM-1) microparticles were reduced at 3 and 6 months after IFN-β1a therapy, but did not reach statistical significance until 12 months (* = p < 0.05).